[1]CurrentPatentAssignee:PFIZERINC-US2005/256310,2005,A1Locationinpatent:Page/Pagecolumn12
617718-45-3
159603-42-6
288315-02-6
107128-00-7
36476-88-7
1965305-27-4
932986-18-0 | N-(2-(2-(4-Chlorophenyl)thiazol-4-yl)ethyl)butyramide | AA00GT9H | MFCD08009374
88280-58-4 | 3-Bromodiphenylamine | AA00GTD5 | MFCD07369780
9027-60-5 | EC 4.1.3.3 | AA00GTKP | MFCD00131656
915920-91-1 | 5-(Cyclohexylthio)-2-furaldehyde | AA00GTOG | MFCD08691800
879132-46-4 | 1-((2-(Trimethylsilyl)ethoxy)methyl)-1h-pyrrolo[2,3-b]pyridine | AA00GTUI | MFCD20126209
862189-95-5 | Mirodenafil | AA00GU1I | MFCD09954134
917393-39-6 | Lorediplon | AA00GU63 | MFCD27987938
871217-49-1 | N'-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-N-METHYLFURAN-2-CARBOXIMIDAMIDE | AA00GUA5 | MFCD07348573
923710-57-0 | 5-Ethoxy-2-thien-2-yl-1,3-oxazole-4-carboxylic acid | AA00GUD9 | MFCD08691313
916176-61-9 | 6-Fluoropyridine-2-boronic acid | AA00GULA | MFCD08705713